Navigation Links
"Make AIDS Therapy affordable" - Physicians demand

AIDS in developing countries is a threeat to the globe as 95% of the AIDS victims dwell in here. In the United Nations General Assembly Special Session on HIV/AIDS, physicians demanded to bring down the cost of anti retroviral therapy that would cater the AIDS victims in developing countries.

Dr. Anne-Valerie Kaninda, medical advisor for Doctors without borders (commonly known as Medicines Sans Frontieres, or MSF), MSF provides healthcare assistance in 18 countries that are overburdened with infectious disease, war and disasters, came out with the point that these 34 million people in developing countries cannot be abondoned the treatment just because of the cost of these drugs.

Dr. Kaninda, at an MSF-sponsored panel discussion pointed that expensive antiretroviral therapies - are primarily the privilege of a small minority of patients living in a handful of rich countries while a large majority of HIV victims are from developing world.

Speakers at the meeting focused onto deliver HIV/AIDS care in a countries, including the Ukraine, Thailand, Kenya and Cameroon. They variously noted that abject poverty, government indifference and corruption, lack of public education and cultural taboos and stigma contribute to raise in the infection rate and lack of resources. Unanimousity established over the fact that main culprit has been the astronomic price of cutting-edge antiretroviral medications.

Dr. Chris Ouma of the AIDS treatment organization Action Aid Kenya "Our people have families, homes, feelings, aspirations and jobs. But unfortunately their income is such that they are not able to afford the drugs they need. So I really don't think respecting the monopoly of a drug company in the face of AIDS is a good argument. AIDS is unique and I think we have to draw a line."
'"/>




Page: 1

Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Consensus on "Combination Therapy" for Breast Cancer
3. Gene Therapy shows promise in treating Hemophilia
4. Hormone replacement Therapy a headache
5. Simple Therapy
6. Therapy for stopping the spread of cancer cells
7. Gene Therapy Destroys Pancreatic Cancer Cells
8. Letrozole Beats Tamoxifen in Breast Cancer Therapy
9. Garlic Supplements Impede HIV Therapy
10. Gene Therapy For Cystic Fibrosis
11. A new study surpasses Gene Therapy Hurdle
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/4/2016)... ... May 05, 2016 , ... The talus is the part ankle that ... or traffic accidents can cause the talus bone to be fractured, and a high ... a first-of-its-kind procedure using 3D printing technology, internationally renowned orthopedic surgeon Dr. Mark ...
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... ... children has donated 100 of its innovative kicking trainers to St. Jude Children’s ... The SOCKIT is a durable, lightweight rubber band designed to teach children how ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... Camas and Vancouver, WA, has announced the latest beneficiary of their ongoing ... Foundation and their Mammography Program, which provides free mammograms and diagnostic breast ...
(Date:5/4/2016)... ... May 04, 2016 , ... IsoComforter, ... the introduction of the innovative newly improved Iso-Hip Wrap. The newly designed ... plush design enhances comfort and enables the patient to enjoy the benefits of ...
(Date:5/4/2016)... ... May 04, 2016 , ... A new collaboration will ... The Duke Clinical Research Institute (DCRI) and analytics leader SAS will provide researchers worldwide ... collected by the Duke University Health System. , The DCRI and SAS share ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... 2016  It,s time for an upgrade. There are many medical recorders on the ... LCD, the illustrious DVMAXX HD  offers unparalleled connectivity and functionality.  Ampronix  is a ... class manufacturer of innovative technology.  Photo - http://photos.prnewswire.com/prnh/20160503/363416 ... ... ...
(Date:5/4/2016)... 4, 2016 Valeritas Holdings, Inc. ... alternative public offering (APO). This was accomplished via a ... Inc. and a private placement of approximately 5 million ... share. Under the terms of the reverse ... Holdings, Inc. will trade on the OTC Markets under ...
(Date:5/4/2016)... 4, 2016 Research ... "Global Acute lymphocytic Leukemia Market and Competitive ... offering.       (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... Leukemia Market and Competitive Landscape Highlights 2016, ... pipeline products, Acute Lymphocytic Leukemia epidemiology, Acute ...
Breaking Medicine Technology: